FALCO HOLDINGS Co., Ltd. (4671.T)
JPY 2332.0
(0.39%)
JPY 2332.0
(0.39%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 817 Million JPY | -70.83% |
| 2022 | 2.8 Billion JPY | -31.15% |
| 2021 | 4.06 Billion JPY | -31.1% |
| 2020 | 5.9 Billion JPY | 68.25% |
| 2019 | 3.5 Billion JPY | 39.75% |
| 2018 | 2.51 Billion JPY | -14.5% |
| 2017 | 2.93 Billion JPY | 21.97% |
| 2016 | 2.4 Billion JPY | 10.66% |
| 2015 | 2.17 Billion JPY | 13.93% |
| 2014 | 1.91 Billion JPY | -57.01% |
| 2013 | 4.44 Billion JPY | -48.22% |
| 2012 | 8.58 Billion JPY | -19.01% |
| 2011 | 10.59 Billion JPY | -14.63% |
| 2010 | 12.41 Billion JPY | -1.55% |
| 2009 | 12.6 Billion JPY | 37.05% |
| 2008 | 9.19 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 500 Million JPY | -38.8% |
| 2023 FY | 817 Million JPY | -70.83% |
| 2023 Q2 | 500 Million JPY | 66.67% |
| 2023 Q4 | 817 Million JPY | -30.47% |
| 2023 Q3 | 1.17 Billion JPY | 135.0% |
| 2023 Q1 | 300 Million JPY | -89.29% |
| 2022 Q4 | 2.8 Billion JPY | 10.28% |
| 2022 Q3 | 2.54 Billion JPY | -11.56% |
| 2022 Q1 | 3.02 Billion JPY | -25.69% |
| 2022 FY | 2.8 Billion JPY | -31.15% |
| 2022 Q2 | 2.87 Billion JPY | -5.0% |
| 2021 Q4 | 4.06 Billion JPY | 25.56% |
| 2021 Q2 | 3.68 Billion JPY | -7.72% |
| 2021 FY | 4.06 Billion JPY | -31.1% |
| 2021 Q1 | 3.98 Billion JPY | -32.45% |
| 2021 Q3 | 3.24 Billion JPY | -11.96% |
| 2020 FY | 5.9 Billion JPY | 68.25% |
| 2020 Q1 | 5.71 Billion JPY | 62.92% |
| 2020 Q2 | 5.15 Billion JPY | -9.76% |
| 2020 Q3 | 4.82 Billion JPY | -6.44% |
| 2020 Q4 | 5.9 Billion JPY | 22.31% |
| 2019 FY | 3.5 Billion JPY | 39.75% |
| 2019 Q4 | 3.5 Billion JPY | 43.81% |
| 2019 Q1 | 2.5 Billion JPY | -0.32% |
| 2019 Q2 | 2.44 Billion JPY | -2.52% |
| 2019 Q3 | 2.44 Billion JPY | 0.0% |
| 2018 Q3 | 2.39 Billion JPY | 0.0% |
| 2018 Q4 | 2.51 Billion JPY | 5.06% |
| 2018 FY | 2.51 Billion JPY | -14.5% |
| 2018 Q2 | 2.39 Billion JPY | -3.43% |
| 2018 Q1 | 2.47 Billion JPY | -15.73% |
| 2017 FY | 2.93 Billion JPY | 21.97% |
| 2017 Q4 | 2.93 Billion JPY | 4.48% |
| 2017 Q3 | 2.81 Billion JPY | 26.0% |
| 2017 Q2 | 2.23 Billion JPY | -0.31% |
| 2017 Q1 | 2.23 Billion JPY | -7.06% |
| 2016 Q2 | 1.77 Billion JPY | 7.71% |
| 2016 FY | 2.4 Billion JPY | 10.66% |
| 2016 Q3 | 1.77 Billion JPY | 0.0% |
| 2016 Q1 | 1.64 Billion JPY | -24.26% |
| 2016 Q4 | 2.4 Billion JPY | 35.66% |
| 2015 Q3 | 1.46 Billion JPY | 12.74% |
| 2015 FY | 2.17 Billion JPY | 13.93% |
| 2015 Q4 | 2.17 Billion JPY | 49.04% |
| 2015 Q2 | 1.29 Billion JPY | 83.69% |
| 2015 Q1 | 705 Million JPY | -63.09% |
| 2014 Q4 | 1.91 Billion JPY | 68.58% |
| 2014 Q3 | 1.13 Billion JPY | -10.22% |
| 2014 Q2 | 1.26 Billion JPY | -40.08% |
| 2014 Q1 | 2.1 Billion JPY | -52.6% |
| 2014 FY | 1.91 Billion JPY | -57.01% |
| 2013 Q2 | 4.68 Billion JPY | -10.6% |
| 2013 Q1 | 5.24 Billion JPY | -38.9% |
| 2013 FY | 4.44 Billion JPY | -48.22% |
| 2013 Q3 | 4.55 Billion JPY | -2.75% |
| 2013 Q4 | 4.44 Billion JPY | -2.52% |
| 2012 Q3 | 6.94 Billion JPY | -2.91% |
| 2012 Q1 | 7.29 Billion JPY | -31.18% |
| 2012 Q4 | 8.58 Billion JPY | 23.49% |
| 2012 Q2 | 7.15 Billion JPY | -1.85% |
| 2012 FY | 8.58 Billion JPY | -19.01% |
| 2011 FY | 10.59 Billion JPY | -14.63% |
| 2011 Q1 | 7.95 Billion JPY | -35.87% |
| 2011 Q2 | 8.25 Billion JPY | 3.77% |
| 2011 Q3 | 7.79 Billion JPY | -5.61% |
| 2011 Q4 | 10.59 Billion JPY | 35.9% |
| 2010 FY | 12.41 Billion JPY | -1.55% |
| 2010 Q4 | 12.41 Billion JPY | 46.15% |
| 2010 Q3 | 8.49 Billion JPY | -4.71% |
| 2010 Q1 | 8.41 Billion JPY | 0.0% |
| 2010 Q2 | 8.91 Billion JPY | 5.91% |
| 2009 FY | 12.6 Billion JPY | 37.05% |
| 2009 Q3 | 11.41 Billion JPY | 0.0% |
| 2008 Q4 | 12.02 Billion JPY | 0.0% |
| 2008 FY | 9.19 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 26.33 Billion JPY | 96.897% |
| DNA Chip Research Inc. | - JPY | -Infinity% |
| Cosmo Bio Company,Limited | 20 Million JPY | -3985.0% |
| H.U. Group Holdings, Inc. | 81.94 Billion JPY | 99.003% |
| BML, Inc. | 5.26 Billion JPY | 84.482% |
| Human Metabolome Technologies, Inc. | 226.3 Million JPY | -261.02% |
| Precision System Science Co., Ltd. | 1.36 Billion JPY | 40.218% |